UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients : results after 1 year

Nephrology, dialysis, transplantation, 1996, Vol.11 (1), p.165-172

1996

Volltextzugriff (PDF)

A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients

Transplantation, 1996-10, Vol.62 (8), p.1063-1068

1996

Volltextzugriff (PDF)

Cyclosporin new oral formulation for early oral immunosuppressive therapy in liver transplant recipients

Transplantation proceedings, 1997-02, Vol.29 (1), p.544-546

1997

Volltextzugriff (PDF)

Absorption of cyclosporine neoral early after liver transplantation : Influence of bile on oral absorption

Transplantation proceedings, 1996-08, Vol.28 (4), p.2237-2238

1996

Volltextzugriff (PDF)

Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients

Transplant international, 1995-07, Vol.8 (4), p.324-326

1995

Volltextzugriff (PDF)

Comparison of efficacy, safety, and tolerability of neoral vs sandimmun in de novo renal transplant patients over 24 months' treatment

Transplantation proceedings, 1997-02, Vol.29 (1), p.275-276

1997

Volltextzugriff (PDF)

Long-term experience with sandimmun neoral: Results in de novo and stable renal transplant patients after 24-month treatment

Transplantation proceedings, 1997-11, Vol.29 (7), p.2945-2947

1997

Volltextzugriff (PDF)

Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year

Clinical nephrology, 1996-05, Vol.45 (5), p.326

1996

Volltextzugriff (PDF)

Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients

Transplantation proceedings, 1994-10, Vol.26 (5), p.2988-2993

1994

Volltextzugriff (PDF)

Mechanism of Free and Conjugated Neocarzinostatin Activity: Studies on Chromophore and Protein Uptake Using a Transferrin-Neocarzinostatin Conjugate

Zeitschrift für Naturforschung C. A journal of biosciences, 1997-03, Vol.52 (3), p.245-254

1997

Volltextzugriff (PDF)

Conversion from sandimmun to sandimmun neoral in patients with stable renal allografts : results after 1 month

Transplantation proceedings, 1994-10, Vol.26 (5), p.2944-2948

1994

Volltextzugriff (PDF)

Successful reconversion from tacrolimus to cyclosporine A neoral in pediatric liver recipients

Transplantation proceedings, 1996-08, Vol.28 (4), p.2276-2278

1996

Volltextzugriff (PDF)

Absorption of cyclosporine neoral early after liver transplantation : Is it Possible to abandon intravenous cyclosporine A application ?

Transplantation proceedings, 1996-08, Vol.28 (4), p.2239-2240

1996

Volltextzugriff (PDF)

Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group

Transplantation proceedings, 1997-11, Vol.29 (7), p.2945

1997

Volltextzugriff (PDF)

CyA-NOF for early oral CyA-based immunosuppression in patients after liver transplantation

Transplantation proceedings, 1996-04, Vol.28 (2), p.900-905

1996

Volltextzugriff (PDF)

BASILIXIMAB (SIMULECT™) REDUCES ACUTE REJECTIONS, CMV-INFECTIONS AND DURATION OF HOSPITAL STAY IN RENAL ALLOGRAFT PATIENTS

Transplantation, 1998-05, Vol.65 (Supplement), p.256

1998

Volltextzugriff (PDF)

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year

Nephrology, dialysis, transplantation, 1996-01, Vol.11 (1), p.165-172

1996

Volltextzugriff (PDF)

Long-term results of conversion from existing to microemulsion formulation of cyclosporine

Transplantation proceedings, 1996-08, Vol.28 (4), p.2207-2213

1996

Volltextzugriff (PDF)

Clinical experience transferring kidney transplant patients from Sandimmun to Sandimmun Neoral--results after 3 months

Clinical nephrology, 1995-01, Vol.43 Suppl 1, p.S27

1995

Volltextzugriff (PDF)

Clinical experience in transferring kidney transplant patients from Sandimmun to Sandimmun Neoral : results after 6 months

Transplantation proceedings, 1995-10, Vol.27 (5), p.2679-2682

1995

Volltextzugriff (PDF)

ESTIMATION OF NEOCARZINOSTATIN ACTIVITY IN CONJUGATES WITH MONOCLONAL ANTIBODIES

The Journal of Antibiotics, 1990/08/25, Vol.43(8), pp.1051-1054

1990

Volltextzugriff (PDF)

Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies

Journal of antibiotics, 1991, Vol.44 (10), p.1148-1154

1991

Volltextzugriff (PDF)

Influence of bile on cyclosporin absorption fror microemulsion formulation in primary liver transplant recipients

Transplant international, 1995, Vol.8 (4), p.324-326

1995

Volltextzugriff (PDF)

Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver‐grafted patient with severe cholestasis

Transplant international, 1994-03, Vol.7 (2), p.147-148

1994

Volltextzugriff (PDF)

Favourable clinical results of sandimmun-neonral in malabsorbing liver and heart transplant recipients

Transplantation proceedings, 1994, Vol.26 (5), p.2988-2993

1994

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(17)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Administration, Oral
(15)
Cyclosporine - Administration & Dosage
(15)
Male
(15)
Biological And Medical Sciences
(14)
Immunology
(14)
Medical Sciences
(14)
Middle Aged
(14)
Female
(13)
Pharmacology. Drug Treatments
(13)
Transplantation
(13)
Immunomodulators
(12)
Surgery
(12)
Cyclosporine - Therapeutic Use
(11)
Immunosuppressive Agents - Administration & Dosage
(11)
Adult
(9)
Cyclosporine - Pharmacokinetics
(9)
Time Factors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients : results after 1 year

A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients

Cyclosporin new oral formulation for early oral immunosuppressive therapy in liver transplant recipients

Absorption of cyclosporine neoral early after liver transplantation : Influence of bile on oral absorption

Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients

Comparison of efficacy, safety, and tolerability of neoral vs sandimmun in de novo renal transplant patients over 24 months' treatment

Long-term experience with sandimmun neoral: Results in de novo and stable renal transplant patients after 24-month treatment

Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year

Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients

Mechanism of Free and Conjugated Neocarzinostatin Activity: Studies on Chromophore and Protein Uptake Using a Transferrin-Neocarzinostatin Conjugate

Conversion from sandimmun to sandimmun neoral in patients with stable renal allografts : results after 1 month

Successful reconversion from tacrolimus to cyclosporine A neoral in pediatric liver recipients

Absorption of cyclosporine neoral early after liver transplantation : Is it Possible to abandon intravenous cyclosporine A application ?

Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group

CyA-NOF for early oral CyA-based immunosuppression in patients after liver transplantation

BASILIXIMAB (SIMULECT™) REDUCES ACUTE REJECTIONS, CMV-INFECTIONS AND DURATION OF HOSPITAL STAY IN RENAL ALLOGRAFT PATIENTS

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year

Long-term results of conversion from existing to microemulsion formulation of cyclosporine

Clinical experience transferring kidney transplant patients from Sandimmun to Sandimmun Neoral--results after 3 months

Clinical experience in transferring kidney transplant patients from Sandimmun to Sandimmun Neoral : results after 6 months

ESTIMATION OF NEOCARZINOSTATIN ACTIVITY IN CONJUGATES WITH MONOCLONAL ANTIBODIES

Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies

Influence of bile on cyclosporin absorption fror microemulsion formulation in primary liver transplant recipients

Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver‐grafted patient with severe cholestasis

Favourable clinical results of sandimmun-neonral in malabsorbing liver and heart transplant recipients

Suchergebnisse filtern